LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

Anthropic Chief Executive Officer Dario Amodei said that his AI startup is racing to secure the computing power needed to meet demand for its generative AI chatbot Claude. “The surge in demand ...

Feb. 1 is Change Your Password Day, and you may think that good cyber hygiene means creating new, robust passwords every few months. Not so fast. I've been writing ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Then it does something unusual: It offers a human fact-check and the option to ... But, the AI went on, “Pearl’s situation is unique because it generates content using AI.” ...